Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

Patients who get an add-on medication soon after a heart attack have a better prognosis than those who receive it later, or ...

Adding ezetimibe (Zetia) therapy to statins early after a heart attack improved outcomes, Swedish national records suggested.

Treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks, strokes, and death over a decade, according to ...

Thousands of heart attacks could be prevented if the NHS prescribed a "low-cost" drug combination, according to new research. A study conducted by an international team of scientists suggests that ...

The new clinical guide reveals gender-specific cardiovascular risks and prevention strategies for women across all life ...

The Philippine Health Insurance Corporation (PhilHealth) has paid the Philippine General Hospital (PGH) PHP22.8 million for ...

Analysis suggests that treating heart attack patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.

The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for ...

The following is a summary of “Association of Early Noninvasive Cardiac Stress Testing With Acute Myocardial Infarction and ...

For patients with OHCA, a critical factor in determining survival and long-term outcomes is how quickly CPR is initiated.

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...